
Cobepa Risk Report
Generated on July 16, 2025
1
Risks
Summary
π‘οΈ Financial & Liquidity
Cobepa's recent activities highlight a vibrant participation in the acquisition and investment space, congruent with its specialties in investment and private equity. Noteworthy is the involvement in major financing deals and acquisitions, which underscores the company's active role in managing its financial health. Key acquisitions and majority investments consistently occur within Cobepa's strategic framework, seemingly supporting its growth trajectory.
- White & Case advised Cobepa on the acquisition of a majority stake in Smart SD π January 29, 2024.
- Cobepa, together with Inflexion, acquired a minority stake in Easyfairs for β¬600 million π May 31, 2024.
- Cobepa closed the acquisition of Ned Stevens, a pivotal move, π November 2, 2022.
- Cobepa's acquisition of Salice was backed by β¬230 million financing, highlighting strong financial capabilities π June 30, 2022.
- During March 2022, Cobepa and Reaction Biology finalized a transaction showcasing Cobepa's M&A prowess.
News & Media
Stay informed with real-time news signals across financial, legal, and operational domains.
Profile
Specialties
Investment, LBO, Private Equity